๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Deferasirox a strong contender for iron overload in all ages

โœ Scribed by Sullivan, S

Book ID
120854603
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2005
Weight
196 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase 1/2, dose-escalation trial of de
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis
โœ Pradyumna Phatak; Pierre Brissot; Mark Wurster; Paul C Adams; Herbert L. Bonkovs ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 391 KB ๐Ÿ‘ 1 views

Hereditary hemochromatosis (HH) is characterized by increased intestinal iron absorption that may result in iron overload. Although phlebotomy is widely practiced, it is poorly tolerated or contraindicated in patients with anemias, severe heart disease, or poor venous access, and compliance can vary